Arti-Cell Forte RSS Authorised This medicine is authorised for use in the European Union chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells Medicine Veterinary Authorised
Page contentsPage contents Overview Product information Product details Authorisation details Assessment history News on Arti-Cell Forte More information on Arti-Cell Forte Topics Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Arti-Cell Forte : EPAR - Medicine overview English (EN) (81.94 KB - PDF)First published: 07/05/2019 Last updated: 14/10/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View español (ES) (81.97 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View čeština (CS) (93.99 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View dansk (DA) (83.34 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View français (FR) (82.44 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View íslenska (IS) (83.29 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View italiano (IT) (82.29 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View magyar (HU) (94.15 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Malti (MT) (95.95 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View norsk (NO) (82 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View polski (PL) (95.62 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View português (PT) (83.01 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View română (RO) (94.17 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Suomi (FI) (81.54 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View svenska (SV) (82.05 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Product information Arti-Cell Forte : EPAR - Product Information English (EN) (81.49 KB - PDF)First published: 07/05/2019 Last updated: 14/10/2024 View Other languages (25) български (BG) (91.78 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View español (ES) (81.51 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View čeština (CS) (92.48 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View dansk (DA) (82.05 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Deutsch (DE) (81.72 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View eesti keel (ET) (81.22 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View ελληνικά (EL) (91.79 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View français (FR) (81.63 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View hrvatski (HR) (91.56 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View íslenska (IS) (81.52 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Gaeilge (GA) (81.36 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View italiano (IT) (81.76 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View latviešu valoda (LV) (92.14 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View lietuvių kalba (LT) (92.19 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View magyar (HU) (92.76 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Malti (MT) (93.86 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Nederlands (NL) (81.15 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View norsk (NO) (81.52 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View polski (PL) (93.22 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View português (PT) (82.53 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View română (RO) (91.73 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View slovenčina (SK) (81.75 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View slovenščina (SL) (81.76 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Suomi (FI) (81.11 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View svenska (SV) (81.47 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Arti-Cell Forte : EPAR - All Authorised presentations English (EN) (81.94 KB - PDF)First published: 07/05/2019 Last updated: 14/10/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View español (ES) (81.97 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View čeština (CS) (93.99 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View dansk (DA) (83.34 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View français (FR) (82.44 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View íslenska (IS) (83.29 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View italiano (IT) (82.29 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View magyar (HU) (94.15 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Malti (MT) (95.95 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View norsk (NO) (82 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View polski (PL) (95.62 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View português (PT) (83.01 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View română (RO) (94.17 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Suomi (FI) (81.54 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View svenska (SV) (82.05 KB - PDF) First published: 07/05/2019 Last updated: 14/10/2024 View Product details Name of medicine Arti-Cell Forte Active substance chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells International non-proprietary name (INN) or common name chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells Pharmacotherapeutic groupOther drugs for disorders of the musculo-skeletal system Authorisation details EMA product number EMEA/V/C/004727 Assessment history Expand section Collapse section Changes since initial authorisation of medicine Arti-Cell Forte : EPAR - Procedural steps taken and scientific information after authorisation English (EN) (81.94 KB - PDF)First published: 07/05/2019 Last updated: 14/10/2024 View Initial marketing authorisation documents Arti-Cell Forte : EPAR - Public assessment reportAdopted English (EN) (81.49 KB - PDF)First published: 07/05/2019 Last updated: 14/10/2024 View CVMP summary of positive opinion for Arti-Cell ForteAdopted Reference Number: EMA/CVMP/332343/2018 English (EN) (69.39 KB - PDF)First published: 22/06/2018 Last updated: 22/06/2018 View News on Arti-Cell Forte Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-18 April 202419/04/2024 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 December 202308/12/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 October 202207/10/2022 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 February 202221/02/2022 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 6-7 October 202009/10/2020 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 18-20 February 202021/02/2020 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 19–21 June 201822/06/2018 First stem cell-based veterinary medicine recommended for marketing authorisation22/06/2018 More information on Arti-Cell Forte Arti-Cell Forte / RenuTend - direct animal healthcare professional communication (DaHPC) Topics Advanced therapies Medicines This page was last updated on 14/10/2024 Share this page